Annovis Bio, Inc. (ANVS) NYSE
1.84
-0.02(-1.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.84
-0.02(-1.08%)
Currency In USD
| Market Cap | 71.11M |
| Enterprise Value | -19.46B |
| P/E Ratio | -1.58 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.71 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 660.37 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.37 |
| Return On Equity | -1.59 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -29.7M |
| Net Income | -28.85M |
| Diluted EPS | -1.4 |
| Total Cash | 19.53B |
| Total Cash/Share | 787.19 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.8 |
| Book Value Per Share | 0.68 |
| 52-Week Change | 21.85 |
| 52-Week High | 5.5 |
| 52-Week Low | 1.36 |
| Moving Average 50 Days | 2.32 |
| Moving Average 200 Days | 2.7 |
| Average Volume | 674,047 |
| Shares Outstanding | 19.67M |
| % Held by Institutions | 21.53 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |